| 000 | 01537 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250511223053.0 | ||
| 264 | 0 | _c19900723 | |
| 008 | 199007s 0 0 eng d | ||
| 022 | _a0887-2570 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCostanzo-Nordin, M R | |
| 245 | 0 | 0 |
_aProspective randomized trial of OKT3- versus horse antithymocyte globulin-based immunosuppressive prophylaxis in heart transplantation. _h[electronic resource] |
| 260 |
_bThe Journal of heart transplantation _c |
||
| 300 |
_a306-15 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xtherapeutic use |
| 650 | 0 | 4 |
_aAntilymphocyte Serum _xtherapeutic use |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGraft Rejection |
| 650 | 0 | 4 | _aHeart Transplantation |
| 650 | 0 | 4 | _aHorses |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunosuppression Therapy |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xtherapeutic use |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aMuromonab-CD3 |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
| 650 | 0 | 4 |
_aT-Lymphocytes _ximmunology |
| 700 | 1 | _aO'Sullivan, E J | |
| 700 | 1 | _aJohnson, M R | |
| 700 | 1 | _aWinters, G L | |
| 700 | 1 | _aPifarre, R | |
| 700 | 1 | _aRadvany, R | |
| 700 | 1 | _aZucker, M J | |
| 700 | 1 | _aScanlon, P J | |
| 700 | 1 | _aRobinson, J A | |
| 773 | 0 |
_tThe Journal of heart transplantation _gvol. 9 _gno. 3 Pt 2 _gp. 306-15 |
|
| 999 |
_c2119250 _d2119250 |
||